Successful generation of CD38KO NK cells from ex vivo expanded PB-NK cells using Cas9/RNP. (A) Workflow for generating CD38KO NK cells from ex vivo expanded PB-NK cells using electroporation of Cas9/RNP. (B) CD38 expression in NK cells before and after Cas9/RNP-mediated CD38 deletion (n = 5; mean ± standard deviation [SD]). (C) Representative fluorescence-activated cell sorter (FACS) analyses of the purified CD38KO NK cells. Each figure indicates the percentage of CD38-expressing NK cells. Isotype controls are depicted with filled histograms. (D) Expansion of CD38WT and CD38KO NK cells.
Figure 1.

Successful generation of CD38KO NK cells from ex vivo expanded PB-NK cells using Cas9/RNP. (A) Workflow for generating CD38KO NK cells from ex vivo expanded PB-NK cells using electroporation of Cas9/RNP. (B) CD38 expression in NK cells before and after Cas9/RNP-mediated CD38 deletion (n = 5; mean ± standard deviation [SD]). (C) Representative fluorescence-activated cell sorter (FACS) analyses of the purified CD38KO NK cells. Each figure indicates the percentage of CD38-expressing NK cells. Isotype controls are depicted with filled histograms. (D) Expansion of CD38WT and CD38KO NK cells.

or Create an Account

Close Modal
Close Modal